Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Vitreoretinal surgery · California | Vitreoretinal surgery · Texas | |
|---|---|---|
| Surgeons, 2024 | 94 | 83 |
| Medicare fee-for-service cases | 7,488 | 6,824 |
| Growth since 2019 (Medicare FFS) | −1.9%/yr | −3.6%/yr |
| Forecast cases (Medicare FFS) | 8,080 in 2030 | 7,210 in 2030 |
| Forecast growth | +1.3%/yr to 2030 | +0.9%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 2.3 | 3.2 |
| Medicare Advantage share | 56% | 59% |
| Out of hospital | 59% (+13 pts since 2019) | 80% (+24 pts since 2019) |
| Cases per surgeon | 80 | 82 |
| Top 10 surgeons' share | 30% | 34% |
| Surgeons growing | 13 | 11 |
| New since the base year | 15 | 12 |
| Likely to stop billing it | 16 by 2026 | 11 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $13K | $12K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.